Approval · Notice of Compliance 34257 · 2024
FIRDAPSE: Notice of Compliance 34257
Issued October 22, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34257
- Date
- October 22, 2024
- Company
- Kye Pharmaceuticals Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a manufacturing site and/or manufacturer involving production of the drug substance
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FIRDAPSE | Not yet assigned | — |
Medicinal ingredients
- AMIFAMPRIDINE PHOSPHATE 10 MG per TAB